Telzir · DIN 02261553 · 50 mg/mL · Oral suspension
General benefit; Health Canada lists this DIN as Cancelled post market since 2024-12-31 — choose a marketed DIN from the same-category list.Discontinued December 31, 2024 · checked November 18, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-12-31 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-12-31 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Telzir · DIN 02261553
Manufacturer: ViiV Healthcare ULC; listing date 2009-01-30
Health Canada: Cancelled post market since 2024-12-31 · brand TELZIR · ATC J05AE07 FOSAMPRENAVIR · form Suspension · route Oral · ingredients FOSAMPRENAVIR (FOSAMPRENAVIR CALCIUM) 50 MG/ML · company Viiv healthcare ulc · schedule Prescription
Telzir: Formulary list price $0.65 per unit (the source does not state the unit; exact figure $0.6535). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02261553)
Source record
DIN 02261553: Telzir
Raw flags: sec3=Y
Item: 081800107; group id 89; item number 0159; lccId None; manufacturer id VIH
Source form: Oral Susp; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.6535; ministry $0.6535
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02261553
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74693
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since December 31, 2024 — choose a marketed DIN from the same-category list.